| The role of pharmacoeconomics in current Indian healthcare system A Ahmad, I Patel, S Parimilakrishnan, GP Mohanta, HC Chung, J Chang Journal of research in pharmacy practice 2 (1), 3, 2013 | 57 | 2013 |
| Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health Q Ma, H Chung, S Shambhu, M Roe, M Cziraky, WS Jones, K Haynes Clinical Trials 16 (4), 419-430, 2019 | 13 | 2019 |
| Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a US Commercially Insured and Medicare Advantage Population. H Chung, G Deshpande, J Zolotarjova, RA Quimbo, DM Kern, PT Cochetti, ... J Manag Care Spec Pharm 25 (5), 612-620, 2019 | 8 | 2019 |
| Factors that predict the use of psychotropics among children and adolescents with PTSD: Evidence from private insurance claims R Soria-Saucedo, JH Chung, H Walter, M Soley-Bori, LE Kazis Psychiatric services 69 (9), 1007-1014, 2018 | 2 | 2018 |
| Medical and Pharmacy Claims Analysis Comparing Outcomes with Extended-Release Topiramate (Trokendi XR®) and Immediate-Release Topiramate (P2. 169) W O’Neal, EE Hur, T Liranso, H Chung, T Gu, RM Turner Neurology 88 (16 Supplement), P2. 169, 2017 | 1 | 2017 |
| Administrative claims data to support pragmatic clinical trial outcome ascertainment using PCORnet adaptable trial as an example Q Ma, K Haynes, H Chung, S Shambhu, M Roe, WS Jones PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 148-148, 2018 | | 2018 |
| Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR (R)(extended-release topiramate) vs. Immediate-Release Topiramate as Migraine Preventives W O'Neal, EE Hur, T Liranso, H Chung, T Gu, O Tunceli, RM Turner CEPHALALGIA 37, 88-89, 2017 | | 2017 |
| Cognitive Tolerability with Once-Daily Trokendi XR (R)(extended-release topiramate) vs. Immediate-Release Topiramate W O'Neal, EE Hur, T Liranso, P Barr, H Chung, T Gu, O Tunceli, ... CEPHALALGIA 37, 87-88, 2017 | | 2017 |
| Cognitive Tolerability with Once-Daily Trokendi XRVR (extended-release Topiramate) vs. Immediate-Release Topiramate W O'Neal, E Hur, T Liranso, S Brittain, P Barr, H Chung, T Gu, O Tunceli, ... HEADACHE 57, 180-181, 2017 | | 2017 |
| Medication Use among Patients Diagnosed with Headache and Migraine in a Large National Commercial Payer Database: A Retrospective Study PA Morrow, H Chung, J Visaria, BE Atiya, Y Tanaka, AB Araujo, DM Kern, ... HEADACHE 57, 140-141, 2017 | | 2017 |
| DECREASED RATES OF HEALTH PLAN DISENROLLMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS H Chung, DM Kern, V Willey, R Quimbo, G Deshpande, PT Cochetti VALUE IN HEALTH 20 (5), A378-A379, 2017 | | 2017 |
| DECREASED RATES OF HEALTH PLAN DISENROLLMENT FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE DM Kern, V Willey, R Quimbo, H Chung, G Deshpande, PT Cochetti VALUE IN HEALTH 20 (5), A379-A379, 2017 | | 2017 |
| (370) Cognitive tolerability and health outcomes with once-daily Trokendi XR®(extended-release topiramate) in migraineurs W O’Neal, E Hur, T Liranso, S Brittain, P Barr, H Chung, T Gu, O Tunceli, ... The Journal of Pain 18 (4), S67, 2017 | | 2017 |
